Science
Mechanism of Action
This ingredient operates by modulating the Wnt/beta-catenin signaling pathway. It specifically directs the gene co-activator choice between CBP and p300, essentially providing a biological 'instruction' that encourages skin stem cells to differentiate into active tissue-producing cells rather than entering a state of senescence. This results in enhanced collagen synthesis and a reinforced dermal matrix.
Research
Clinical Evidence
High confidence0.1%
Key findings
- 01 Gene expression analysis (SID 2012) demonstrated down-regulation of POMC and up-regulation of MC1R at 0.1%, reversing markers of photoaging and lentigines.
- 02 Multicenter trials using concentrations between 0.01% and 0.1% confirmed measurable improvements in skin density, luminosity, and a reduction in fine line depth.
Transparency
Dusting Analysis
Due to its high efficacy at very low concentrations, many formulations may include this ingredient at levels below 0.01% for marketing purposes. Therapeutic benefits are primarily validated at or above the 0.01% threshold.
The Formula
Formulation
Stability
The molecule features a C12 lauroyl ester linkage, making it highly lipophilic but sensitive to hydrolysis. Formulation must avoid extreme pH levels (below 4.0 or above 7.5) to prevent ingredient degradation.
Synergies
- Lipids
- Carrier oils
- Non-acidic antioxidants
Conflicts
- Strong oxidizing agents
- Strong mineral acids
- Highly alkaline bases
Safety
Safety Profile
Manufacturer dermatological patch testing indicates the compound is non-mutagenic, non-irritating, and non-sensitizing.
Your Skin
Skin Compatibility
Our Assessment
Verdict
A high-tech, evidence-based modulator that offers a sophisticated alternative to traditional retinoids for skin density and pigment correction.
Related
Similar Ingredients
Finding similar ingredients…
References
Sources